Noble Life Sciences, Inc.
11
Michelle M. Harner
06/22/2025
04/20/2026
Yes
v
| PlnDue, EXHIBITS, APFee |
Assigned to: Judge Michelle M. Harner Chapter 11 Voluntary Asset |
| ||||||||||
| Case Administrator: | Kelly Horning | ||||||||||
| Team 2 Phone: | 301-344-3965 |
Debtor Noble Life Sciences, Inc.
1500 Fannie Dorsey Road Sykesville, MD 21784 CARROLL-MD Tax ID / EIN: 27-2336482 |
represented by |
Robert B. Scarlett
Scarlett & Croll, P.A. 306 W. Chesapeake Ave. Baltimore, MD 21204 410-468-3100 Fax : 410-332-4026 Email: RScarlett@ScarlettCroll.com |
|
| ||
U.S. Trustee US Trustee - Baltimore
Garmatz Federal Courthouse 101 West Lombard Street Suite 2625 Baltimore, MD 21201 (410) 962-4300 Fax : (410) 962-3537 Email: USTPRegion04.BA.ECF@USDOJ.GOV |
represented by |
Hugh M. (UST) Bernstein
Office of U.S. Trustee 101 W. Lombard Street Suite 2625 Baltimore, MD 21201 (410) 962-7771 Email: hugh.m.bernstein@usdoj.gov Omnia Shedid
DOJ-Ust 101 West Lombard Street Suite 2625 Baltimore, MD 21201 410-962-4300 TERMINATED: 08/13/2025 |
| Date Filed | # | Docket Text |
|---|---|---|
| 04/20/2026 | 278 | Line filing Redline Copies on behalf of Noble Life Sciences, Inc. Filed by Robert B. Scarlett. (Attachments: # (1) Exhibit Redline Copy of Second Amended Plan to First Amended Plan # (2) Exhibit 2 - Redline Comparing Second Amended Disclosure Statement to First Amended Disclosure Statement) (Scarlett, Robert) |
| 04/19/2026 | 277 | Disclosure Statement Second Amended Filed by Noble Life Sciences, Inc.. (Attachments: # (1) Exhibit 1 - Asset and Liquidation Analysis # (2) Exhibit 2 - Lab Appraisal Analysis # (3) Exhibit 3 - Debtor's Physical Furniture and Chatel Appraisal # (4) Exhibit 4 - Accounts Receivables Valuation Analysis # (5) Exhibit 5 - UCC Statements # (6) Exhibit 6 - Plan Distribution Analysis # (7) Exhibit 7 - Statement of Cash Flows # (8) Exhibit 8 - Income and Expense Report # (9) Exhibit 9 - Backlog of Work # (10) Exhibit 10 - Outstanding Unbooked Work # (11) Exhibit 11 - Claims being modified # (12) Exhibit 12 - Assumptions of Income # (13) Exhibit 13 - Sources of Income # (14) Exhibit 14 - Assumed Contracts)(Scarlett, Robert) |
| 04/19/2026 | 276 | Second Amended Chapter 11 Plan Filed by Noble Life Sciences, Inc.. (Scarlett, Robert) |
| 03/24/2026 | 275 | Chapter 11 Monthly Operating Report for the Month Ending: 02/28/2026 Filed by Robert B. Scarlett. (Attachments: # (1) Exhibit B to MOR # (2) Exhibit Proffit and Loss for February # (3) Exhibit Balance Sheet # (4) Exhibit Statement of Cash Flows # (5) Exhibit Shore Bank Quickbooks Reconciliation # (6) Exhibit Accounts Payable # (7) Exhibit 7 Accounts Receivables # (8) Exhibit Shore United Statement redacted # (9) Exhibit Amazon Credit Card Statement # (10) Exhibit Southwest Credit Card Statement # (11) Exhibit Citi Bank Credit Card Statement # (12) Exhibit Credit Card Reimbursement Summary # (13) Exhibit 13 Backlog of Accounts Receivables # (14) Exhibit Certificate of Service of February MOR) (Scarlett, Robert) |
| 03/15/2026 | 274 | BNC Certificate of Mailing - PDF Document. (related document(s)[272] Order on Motion to Extend Time). No. of Notices: 1. Notice Date 03/15/2026. (Admin.) |
| 03/15/2026 | 273 | BNC Certificate of Mailing - PDF Document. (related document(s)[271] Order (Generic)). No. of Notices: 1. Notice Date 03/15/2026. (Admin.) |
| 03/13/2026 | 272 | Order Granting Motion To Allow Further Time For The Debtor To File An Disclosure Statement And Amended Plan. (related document(s):[262] Debtors Motion To Allow Further Time For The Debtor To File A Modification To Its Amended Plan To Address Issues Raised In An Srujana Cherukuri And Ramesh Polesh Potla Disclosure Statement (Doc. 240)filed by Debtor Noble Life Sciences, Inc.). The Debtor is hereby granted until April 18, 2026, to further amend its Plan of Reorganization and Disclosure Statement. (Horning, Kelly) |
| 03/13/2026 | 271 | Stipulation And Consent Order Resolving (I) Objection To Claim No. 12-1 Of Srujana Cherukuri And Ramesh Polta [Sic]; And (Ii) Motion For Summary Judgment In Support Of The Debtors Objection To Claim No. 12-1 Of Srujana Cherukuri And Ramesh Polta [Sic] Re: (related document(s)[105] Objection to Claim Number 12 In Re: Cherukuri in the Amount of $3311121.92 filed by Debtor Noble Life Sciences, Inc., [109] Amended Motion For Summary Judgment In Support Of The Debtors Objection To Claim No. 12-1 Of Srujana Cherukuri And Ramesh Polta Filed by Noble Life Sciences, Inc. .). Creditors shall have an allowed nonpriority unsecured claim in the amount of $1,800.00 on account of payments Creditors have made through January 23, 2026 to American Express; In the event Creditors make payments (or additional payments) to Fulton Bank, EBF Holdings LLC and/or American Express, Creditors may file one or more amended proofs of claim for such amounts paid to Fulton bank, EBF Holdings LLC and/or American Express,and any such amended proofs of claim shall not be subject to objection as late-filed and the Debtor reserves all other Defenses to such claim despite this Stipulation. (Horning, Kelly) |
| 03/12/2026 | 270 | BNC Certificate of Mailing - PDF Document. (related document(s)[265] Notice). No. of Notices: 3. Notice Date 03/12/2026. (Admin.) |
| 03/12/2026 | Status Hearing Held: re: [158] Objection to Claim, re: [160] Motion for Summary Judgment, re: [168] Objection to Claim, re: [174] Objection to Claim, re: [178] Motion for Summary Judgment, re: [179] Motion for Summary Judgment, re: [260] Opposition, re: [267] Opposition.(related document(s) [158] Objection to Claim, [159] Certificate of Service, [160] Motion for Summary Judgment, [168] Objection to Claim, [174] Objection to Claim, [178] Motion for Summary Judgment, [179] Motion for Summary Judgment, [260] Opposition, [267] Opposition) (Komisarek, Anna Marie) |